Partner Headlines - LLY

  1. What Is A High Risk Market?

    Benzinga
  2. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt ...

    GuruFocus
  3. Markets Little Changed In Low Volume And Slow News Ahead Of Long ...

    Benzinga
  4. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga
  5. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers ...

    Benzinga
  6. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now ...

    Benzinga
  7. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  8. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  9. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical ...

    Benzinga
  10. Thursday Morning Earnings Reports

    Benzinga
  11. Earnings Scheduled For July 24, 2014

    Benzinga
  12. New Study Shows Beta-Amyloid Imaging Is Associated With Altered ...

    Benzinga
  13. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover ...

    Benzinga
  14. Benzinga's Top #PreMarket Gainers

    Benzinga
  15. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  16. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  17. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  18. Benzinga's Top Upgrades

    Benzinga
  19. Eli Lilly is on the Right Track

    GuruFocus
  20. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  21. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  22. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  23. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  24. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  25. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  26. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent ...

    Benzinga
  27. Eli Lilly insulin trial succeeds

    IBD
  28. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  29. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  30. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  31. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared ...

    Benzinga
  32. Can Pfizer Make Up Its Loss?

    GuruFocus
  33. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  34. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  35. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus
  36. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  37. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  38. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  39. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus
  40. Actavis Earns Over-The-Top Q1

    IBD
  41. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  42. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
  43. China Rule Change Further Opens Yuan To World Markets

    IBD
  44. These Three Pharmaceutical Companies Shake The Market With Their ...

    GuruFocus
  45. Drugmakers' Q1 was anemic

    IBD
  46. Eli Lilly Jr. Made His Firm A Pharmaceutical Power

    IBD
  47. Earnings Scheduled For April 24, 2014

    Benzinga
  48. Big Pharmas Swap Specialties

    IBD
  49. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  50. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  51. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  52. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  53. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  54. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  55. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  56. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  57. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  58. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  59. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  60. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  61. ELI LILLY

    IBD
  62. No Legwork Mondays – Takeda, Eli Lilly, And Actos

    Benzinga
  63. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  64. Lilly, Takeda must pay $9 bil

    IBD
  65. Ethical Drug Stocks Are Struggling

    IBD
  66. UPDATE: BMO Capital Upgrades Eli Lilly

    Benzinga
  67. Takeda, Lilly to 'Vigorously Challenge' Actos Ruling

    FoxBusiness
  68. Benzinga's Top Upgrades

    Benzinga
  69. Takeda Responds to $6B Verdict in Diabetes Drug Case

    Benzinga
  70. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  71. Pfizer Breast-Cancer Drug Scores, But Street Cautious

    IBD
  72. Market Wrap For April 3: Markets Winning Streak Fails To Extend ...

    Benzinga
  73. Wide Moat Stocks: Protection In A Correction

    YCharts
  74. UPDATE: Cowen & Company Upgrades Eli Lilly

    Benzinga
  75. Benzinga's Top Upgrades

    Benzinga
  76. Biotech Auxilium Boosts Position In Men's Health Care

    IBD
  77. Lilly Expands Generic Deal With Prasco

    FoxBusiness
  78. UPDATE: Bank of America Reiterates on Eli Lilly and Co. Following ...

    Benzinga
  79. Merck Snags Baxter Executive As CFO

    FoxBusiness
  80. Box, Online Storage Service Provider, Files For IPO

    IBD
  81. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  82. Forest Laboratories' Recovery

    GuruFocus
  83. Pfizer Breast-Cancer Drug To Show If It's For Real

    IBD
  84. Pharma Patent Cliff: Why Worst Seems Over

    YCharts
  85. Elanco Announces Agreement to Acquire Lohmann Animal Health; ...

    Benzinga
  86. Actavis Q4 Beats Street; Guidance Affirmed For Now

    IBD
  87. Eli Lilly up on lung cancer trial

    IBD
  88. Market Wrap For February 19: Stocks Close Lower, Nasdaq Ends ...

    Benzinga
  89. Lilly Drug Ramucirumab Boosts Lung Cancer Survival

    IBD
  90. Stocks Stage Quiet, Mixed Open; Eli Lilly Up, U.S. Steel Tanks

    IBD
  91. Actavis, Valeant, Jazz: New Roles For Specialty Pharma

    IBD
  92. #PreMarket Primer: Friday, January 31: Emerging Market Turmoil ...

    Benzinga
  93. Eli Lilly

    IBD
  94. Market Wrap For January 30: Markets Focus on Good News

    Benzinga
  95. Lilly's Cymbalta to Trigger 'Severe' Sales Slide

    FoxBusiness
  96. UPDATE: Eli Lilly Posts Drop In Q4 Profit

    Benzinga
  97. #PreMarket Primer: Thursday, January 30: Fed Cut Stimulus By ...

    Benzinga
  98. Tug Of War In Ariad Pharmaceuticals

    Benzinga
  99. Benzinga's M&A Chatter for Monday January 27, 2014

    Benzinga
  100. Income + Value Investing: YCharts Sector Report

    YCharts
Trading Center